Free shipping on all orders over $ 500

 About 8 results found for searched term "Scopolamine" (0.057 seconds)

Cat.No.  Name Target
M3453 Scopolamine hydrobromide Animal Modeling
(-)-Scopolamine hydrobromide; Hyoscine hydrobromide; Scopine hydrobromide
Scopolamine HBr is a competitive muscarinic acetylcholine receptor antagonist with an IC50 of 55.3 nM.It can be used to construct animal models of dry eye.
M3589 Methscopolamine bromide AChR/AChE
(-)-Scopolamine methyl bromide; Hyoscine methyl bromide
Methscopolamine is a muscarinic acetylcholine receptor blocker.
M3590 Butylscopolamine Bromide AChR/AChE
Scopolamine Butylbromide
Butylscopolamine Bromide, is a peripherally acting antimuscarinic, anticholinergic agent used as an abdominal-specific antispasmodic.
M10294 Scopolamine hydrobromide trihydrate AChR/AChE
Scopolamine HBr trihydrate
Scopolamine hydrobromide trihydrate is a competitive muscarinic acetylcholine receptor with an IC50 of 55.3 ± 4.3 nM.
M19097 Scopolamine 5-HT Receptor
Hyoscine; Scopine tropat
Scopolamine is a high affinity (nM) muscarinic antagonist. Scopolamine reversibly inhibited 5-HT3 receptor-responses with an IC50 of 2.09 μM.
M20524 Scopolamine N-Oxide HydrobroMide Monohydrate AChR/AChE
Hyoscine N-oxide HydrobroMide Monohydrate, Genoscopolamine HydrobroMide Monohydrate
Scopolamine N-Oxide is a muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.
M40478 Scopolamine hydrochloride Animal Modeling
Scopolamine hydrochloride is a non-selective and high affinity (≤1 nM) muscarinic antagonist that is used for the prevention of post-operative nausea and vomiting. Scopolamine readily passes the blood brain barrier. Scopolamine also reversibly inhibits 5-HT3 receptor-responses with an IC50 of 2.09 μM.
M58245 Scopolamine Methyl Nitrate Others
Scopolamine Methyl Nitrate is a biochemical reagent that can be used as a biological material or organic compound for life science related research.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.